18 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
;
establishing procedures for the receipt, retention, and treatment of complaints received by us regarding accounting, internal accounting controls
10-Q
2023 Q1
EX-10.1
COYA
Coya Therapeutics Inc
10 May 23
Quarterly report
7:14am
Records.
11.3Coya shall maintain all records and samples (including retention samples) reasonably necessary to support cGMPs and other regulatory … and samples (including retention samples) reasonably necessary to support cGMPs and other regulatory requirements for the Product. All records relating
10-K
zo4csy 5cwk4klc
29 Mar 23
Annual report
4:08pm
424B4
w5i6j
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
EX-10.1
c4egdwvpk 7x
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
153wseo
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-2.1
zgnlu bw8
18 Nov 22
IPO registration
5:06pm
S-1
0gs1y0cz0xs i5b
18 Nov 22
IPO registration
5:06pm
S-1
EX-10.8
eca8qv
18 Nov 22
IPO registration
5:06pm
DRS/A
mgncy1zev3
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
EX-2
qh6hv5u
7 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
n1az5dcqt59m6w gh7g
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
y56i3g2ouxsfd
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next